NCX 284
Alternative Names: NO-diclofenacLatest Information Update: 03 Oct 2002
Price :
$50 *
At a glance
- Originator NicOx
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Pain
Most Recent Events
- 03 Oct 2002 Discontinued - Preclinical for Inflammation (PO)
- 03 Oct 2002 Discontinued - Preclinical for Pain (PO)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed